It’s been 10 years since HealthEdge got its start and the healthcare software company is still standing. But that doesn’t mean it’s been standing still.
Allezoe Medical Holdings (OTC:ALZM) said its Organ Transport Systems subsidiary is preparing for clinical trials of the LifeCradle for preserving donated hearts before transplant.
The company, based in the Philippines, bought OTS in January. The move puts it on a collision course with TransMedics Inc., an Andover, Mass.-based which also has been developing an organ transport system.
Ronda Stryker is pruning one of the family trusts again, letting go of approximately 12 percent of its contents and setting up a payday somewhere close to $120 million — by far, her most profitable year yet selling Stryker Corp. (NYSE:SYK) stock.
Covidien plc (NYSE:COV) will take its Solitaire FR revascularization device directly to regulators rather than wait for additional clinical data, after an independent panel’s review of the data collected so far.
Xoft Inc. could turn out to be a lot more expensive for iCad (NSDQ:ICAD) than the $1 million in cash and the 8.47 million shares of stock it paid for the oncology device manufacturer late last year.
Fresenius Medical Care AG (NYSE:FMS) shares are rebounding from earlier losses and were back to within 50 cents of even for today’s session at $68.14 each, after the German medical device manufacturer announced plans to acquire the Crit-Line system from privately held Hema Metrics. Terms of the deal were not immediately available.
Boston Scientific Corp. (NYSE:BSX) co-founder John Abele will not stand for re-election to the company’s board when his current term expires in May. Two other long-time board members — Marye Anne Fox and Ray Groves — also plan to step down.
Buoyed by strong growth in the vision-care unit during its latest reporting period, The Cooper Companies Inc. (NYSE:COO) last night raised its earnings and revenue forecast for the rest of the year, sending the company’s stock on a tear when trading began this morning.
Executives at NeuroMetrix Inc. (NSDQ:NURO) don’t appear to be in any rush to take on any new debt, but they could borrow up to $7.5 million after signing a one-year extension of a revolving credit facility with Comerica Bank.
Biolase Technology Inc. (NSDQ:BLTI) stock is getting a big boost today, with shares climbing more than 16 percent to reach their best levels since June 2008 after the company received a U.S. patent for tools that make it easier to see structures inside the eye.
Psychemedics Corp. (NYSE:PMD) shares are down about 2 percent, paring earlier losses after the drug-testing firm turning in smaller fourth-quarter profits despite a 19.7 percent jump in Q4 revenues.